Friday, May 27, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Laboratory Reagents for NAMRU-6’s Virology & Emerging Infections Department

by Global Biodefense Staff
April 28, 2017
NAMRU-6 PERU

The Naval Medical Research Unit 6 (NAMRU-6) is seeking to purchase laboratory reagents to be used for molecular diagnosis of Influenza virus, adenovirus, Metapneumovirus, Enterovirus, Rhinovirus, Respiratory Syncytial Virus and Zika virus in the Virology & Emerging Infections Department.

NAMRU-6 is a biomedical research laboratory of the US Navy located in Lima, Peru. Its mission is to identify infectious diseases threats of military and public health importance and to develop and evaluate interventions and products to mitigate those threats.

The current requirement specifically supports NAMRU-6 assays that have been validated using the TaqMan 7500/7500 Fast Real time PCR system and therefore, compatibility of the consumables is a requirement.

The RT-PCR assays have been developed independently for each of NAMRU-6’s Standard Operating Procedures (SOP) and involve a significant effort by laboratory technicians, and supervisors for final approval. Changes to reagents would a full revalidation process, which would delay processing and the timely diagnosis of public health relevant pathogens.

Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work.

Further details are available via Solicitation Number: VEI170003. Capability statements are due by 12:00 PM Local Time (Peru), 02 May 2017.

Tags: AdenovirusEnterovirus D68InfluenzaRFIZika

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Yersinia pestis
Funding News

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

April 8, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC